Gene Cloning Services Market - A Global and Regional Analysis

Focus on Service, Gene Type, Application, End User, and Region - Analysis and Forecast, 2021-2031

Published Year:
SKU:BHP1187SA

$5250

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Market Report Coverage

Gene Cloning Services Market
Forecast Period: 2021-2031
CAGR During Forecast Period: 17.29%

Gene Cloning Services Market

Base Year

2020

Market Size in 2021

$2,338.6 Million

Forecast Period

2021-2031

Value Projection and Estimation by 2031

$11,524.4 Million

CAGR During Forecast Period

17.29%

Number of Tables

11

Number of Pages

197

Number of Figures

170

Market Segmentation

•    Service (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, and Other Service)

•    Gene Type (Standard Gene, Complex Gene, and Other Gene Type)

•    Application (Gene Synthesis, Gene Expression, Vaccine Research, Gene Therapy, and Other)

•    End User (Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User)

Regional Segmentation

•    North America: U.S. and Canada

•    Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe

•    Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific

•    Latin America: Brazil, Mexico, and Rest-of-Latin America

•    Rest-of-the-World

Market Growth Drivers

•    Favorable Funding Scenario for Gene Synthesis and Cloning Services

•    Technological Advancement in Cloning and Sub Cloning Services

•    Rise in Synergistic Activities in Market

Market Challenges

•    Complications Associated with Large-Scale Production of Cloning Vectors

•    Lower Transfection Efficiency

Market Opportunities

•    Rise in Demand for Gene and Cloning Services

•    Limitation of Vectors or Plasmid

•    Development of New Economical Technologies and Services

Key Companies Profiled

Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Charles River Laboratories, Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc.

Key Questions Answered in this Report:

What are the major market drivers, challenges, and opportunities in the global gene cloning services market?

•       How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
        o    Service (gene synthesis service, molecular biology service, custom cloning service, and other service)
        o    Gene Type (standard gene, complex gene, and other gene type)
        o    Application (gene synthesis, gene expression, vaccine research, gene therapy, and other)
        o    End User (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end user)
        o    Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
•    What are the major market drivers, challenges, and opportunities in the global gene cloning services market?
•    What are the underlying structures resulting in the emerging trends within the global gene cloning services market?
•    How is each segment of the global gene cloning services market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
•    What are the key developmental strategies implemented by the major players to sustain in the competitive market?
•    What are the key regulatory implications in developed and developing regions for the gene cloning services market?
•    Who are the leading players with significant offerings to the global gene cloning services market? What is the current market dominance for each of these leading players?
•    What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which gene cloning service gene type is anticipated to have the most promising growth?
•    What are the key applications in the global gene cloning services market? What are the major segments of these applications? What services are dominating these application segments?
•    What are the major services that are employed in the global gene cloning services market? Which is the dominating service?
•    Who are the primary end users of the global gene cloning services market? Which is the fastest-growing end-user segment in the global gene cloning services market?
•    Who are the key manufacturers in the global gene cloning services market, and what are their contributions? Also, what is the growth potential of each major gene cloning services manufacturer?
•    What is the scope of the global gene cloning services market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which gene cloning service application and end user dominate these regions?
•    What are the emerging trends in the global gene cloning services market? How are these trends revolutionizing the diagnostic procedure?
•    Which companies are anticipated to be highly disruptive in the future and why?
•    What are the regulatory procedures that are required to unify the approval process for emerging gene cloning services? How will these enhance the reimbursement scenario?
•    What are the gaps in regularizing optimum gene cloning services adoption in regular healthcare routines? How can these gaps be tackled?

Report Summary

The market value in 2020 was estimated to be $1,983.6 million, and it is expected to reach $11,524.4 million in 2031.

Market Overview

Gene cloning is an essential part of medical decision-making and aid in acquiring information for a wide range of treatment dissemination, accentuating its criticality in healthcare. Gene cloning has a critical role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics.

The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.

Figure: Global Gene Cloning Services Market Snapshot

Global Gene Cloning Services Market

Source: BIS Research Analysis

Factors fueling the growth of the market include a favorable funding scenario for gene synthesis and cloning services, technological advancement in cloning and subcloning services, and a rise in synergistic activities in the market. Despite rapid advancement in the industry, several key issues need to be addressed to facilitate future growth. Complications associated with large-scale production of cloning vectors and lower transfection efficiency are hampering market growth. Further, some opportunities, such as the rise in demand for gene and cloning services, the limitation of vectors or plasmids, and the development of new economic technologies and services, provide growth to the market.

Within the research report, the market has been segmented on the basis of service, gene type, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the prevalence of infectious diseases and various types of cancer on the regional level has created a buzz among companies to invest in advanced technologies such as gene cloning services.

Based on region, Asia-Pacific holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.

Table of Contents

Download this TOC

Get Free Sample

1.1    Product Definition
1.2    Inclusion and Exclusion

2.1    Key Questions Answered in the Report

3.1    Data Source
         3.1.1    Primary Data Source
                     3.1.1.1    Primary Research Methodology
         3.1.2    Secondary Data Sources
                     3.1.2.1    Open Sources
3.2    Market Estimation Model
         3.2.1    Criteria for Company Profiling

4.1    Emerging Applications of Gene Cloning Service
4.2    Addressable Market Size and Growth Potential
4.3    COVID-19 Impact on Global Gene Cloning Services Market
         4.3.1    Impact on Market Size

5.1    Corporate Strategies
         5.1.1    Synergistic Activities
         5.1.2    Acquisitions
         5.1.3    Business Expansion Activities
5.2    Business Strategies
         5.2.1    Service Launches
5.3    Market Share Analysis (by Company)
5.4    Growth-Share Analysis (by Company)

6.1    Legal Requirements and Framework in the U.S.
         6.1.1    FDA Regulations
         6.1.2    Legal Requirements and Framework in Europe
                     6.1.2.1    U.K.
                     6.1.2.2    Germany
         6.1.3    Legal Requirements and Framework in Asia-Pacific
                     6.1.3.1    China
         6.1.4    Japan
                     6.1.4.1    Pharmaceuticals and Medical Devices Agency (PMDA)

7.1    Overview
7.2    Impact Analysis
7.3    Market Drivers
         7.3.1    Favorable Funding Scenario for Gene Synthesis and Cloning Services
         7.3.2    Technological Advancement in Cloning and Sub Cloning Services
         7.3.3    Rise in Synergistic Activities in Market
7.4    Market Restraints
         7.4.1    Complications Associated with Large-Scale Production of Cloning Vectors
         7.4.2    Lower Transfection Efficiency
7.5    Market Opportunities
         7.5.1    Rise in Demand for Gene and Cloning Services
         7.5.2    Limitation of Vectors or Plasmid
         7.5.3    Development of New Economical Technologies and Services

8.1    Overview
8.2    Gene Synthesis Service
8.3    Molecular Biology Service
         8.3.1    PCR Cloning and Sub Cloning Service
         8.3.2    Site-Directed Mutagenesis
         8.3.3    Other Service
8.4    Custom Cloning Service
8.5    Other Service

9.1    Overview
9.2    Stranded Gene
9.3    Complex Gene
9.4    Other Gene Type

10.1    Overview
           10.1.1    Gene Synthesis
           10.1.2    Gene Expression
           10.1.3    Gene Therapy
           10.1.4    Vaccine Research
           10.1.5    Other

11.1    Overview
           11.1.1    Academic and Research Institutions
           11.1.2    Clinical Laboratories
           11.1.3    Pharmaceutical and Biotechnology Companies
           11.1.4    Other End User

12.1    Overview
12.2    North America
           12.2.1    North America Gene Cloning Services Market (Service)
                         12.2.1.1    North America Gene Synthesis Service Market
                         12.2.1.2    North America Molecular Biology Service
                         12.2.1.3    North America Custom Cloning Service Market
                         12.2.1.4    North America Other Service Market
            12.2.2    U.S.
            12.2.3    Canada
12.3    Europe
           12.3.1    Europe Gene Cloning Services Market (Service)
                         12.3.1.1    Europe Gene Synthesis Service Market
                         12.3.1.2    Europe Molecular Biology Service Market
                         12.3.1.3    Europe Custom Cloning Service Market
                         12.3.1.4    Europe Other Service Market
            12.3.2    Germany
            12.3.3    U.K.
            12.3.4    France
            12.3.5    Italy
            12.3.6    Spain
            12.3.7    Switzerland
            12.3.8    Rest-of-Europe
 12.4    Asia-Pacific
           12.4.1    Asia-Pacific Gene Cloning Services Market (Service)
                        12.4.1.1    Asia-Pacific Gene Synthesis Service Market
                        12.4.1.2    Asia-Pacific Molecular Biology Service Market
                        12.4.1.3    Asia-Pacific Custom Cloning Service Market
                        12.4.1.4    Asia-Pacific Other Service Market
          12.4.2    China
          12.4.3    India
          12.4.4    Japan
          12.4.5    Australia
          12.4.6    South Korea
          12.4.7    Rest-of-Asia-Pacific
12.5    Latin America (LATAM)
           12.5.1    Latin America (LATAM) Gene Cloning Services Market (Service)
                        12.5.1.1    Latin America (LATAM) Gene Synthesis Service Market
                        12.5.1.2    Latin America (LATAM) Molecular Biology Service Market
                        12.5.1.3    Latin America (LATAM) Custom Cloning Service Market
                        12.5.1.4    Latin America (LATAM) Other Service Market
          12.5.2    Brazil
          12.5.3    Mexico
          12.5.4    Rest-of-Latin America
12.6    Rest-of-the-World (RoW)
           12.6.1    Rest-of-the-World (RoW) Gene Cloning Services Market (Service)
                         12.6.1.1    Rest-of-the-World (RoW) Gene Synthesis Service Market
                         12.6.1.2    Rest-of-the-World (RoW) Molecular Biology Service Market
                         12.6.1.3    Rest-of-the-World (RoW) Custom Cloning Service Market
                         12.6.1.4    Rest-of-the-World (RoW) Other Service Market

13.1    Overview
13.2    Thermo Fisher Scientific Inc.
           13.2.1    Company Overview
           13.2.2    Role of Thermo Fisher Scientific Inc. in the Global Gene Cloning Services Market
           13.2.3    Key Customers of the Company
           13.2.4    Key Competitors of the Company
           13.2.5    Financials
           13.2.6    Key Insights about the Financial Health of the Company
           13.2.7    SWOT Analysis
13.3    Eurofins Scientific
           13.3.1    Company Overview
           13.3.2    Role of Eurofins Scientific in the Global Gene Cloning Services Market
           13.3.3    Key Customers of the Company
           13.3.4    Key Competitors of the Company
           13.3.5    Financials
           13.3.6    SWOT Analysis
13.4    GenScript
           13.4.1    Company Overview
           13.4.2    Role of GenScript in the Global Gene Cloning Services Market
           13.4.3    Key Customers of the Company
           13.4.4    Key Competitors of the Company
           13.4.5    Financials
           13.4.6    Key Insights about the Financial Health of the Company
           13.4.7    SWOT Analysis
13.5    Merck KGaA
           13.5.1    Company Overview
           13.5.2    Role of Merck KGaA in the Global Gene Cloning Services Market
           13.5.3    Key Customers of the Company
           13.5.4    Key Competitors of the Company
           13.5.5    Financials
           13.5.6    Key Insights about the Financial Health of the Company
           13.5.7    SWOT Analysis
13.6    Takara Bio Inc.
           13.6.1    Company Overview
           13.6.2    Role of Takara Bio Inc. in the Global Gene Cloning Services Market
           13.6.3    Key Customers of the Company
           13.6.4    Key Competitors of the Company
           13.6.5    Financials
           13.6.6    Key Insights about the Financial Health of the Company
           13.6.7    SWOT Analysis
13.7    Charles River Laboratories
           13.7.1    Company Overview
           13.7.2    Role of Charles River Laboratories in the Global Gene Cloning Services Market
           13.7.3    Key Customers of the Company
           13.7.4    Key Competitors of the Company
           13.7.5    Financials
           13.7.6    SWOT Analysis
13.8    Lonza
           13.8.1    Company Overview
           13.8.2    Role of Lonza in the Global Gene Cloning Services Market
           13.8.3    Key Customers of the Company
           13.8.4    Key Competitors of the Company
           13.8.5    Financials
           13.8.6    SWOT Analysis
13.9    Sartorius AG
           13.9.1    Company Overview
           13.9.2    Role of Sartorius AG in the Global Gene Cloning Services Market
           13.9.3    Key Customers of the Company
           13.9.4    Key Competitors of the Company
           13.9.5    Financials
           13.9.6    SWOT Analysis
13.10    Creative Biogene
             13.10.1    Company Overview
             13.10.2    Role of Creative Biogene in the Global Gene Cloning Services Market
             13.10.3    Key Customers of the Company
             13.10.4    Key Competitors of the Company
             13.10.5    SWOT Analysis
13.11    Cellecta, Inc.
             13.11.1    Company Overview
             13.11.2    Role of Cellecta, Inc., in the Global Gene Cloning Services Market
             13.11.3    Key Customers of the Company
             13.11.4    Key Competitors of the Company
             13.11.5    SWOT Analysis
13.12    Synbio Technologies
             13.12.1    Company Overview
             13.12.2    Role of Synbio Technologies in the Global Gene Cloning Services Market
             13.12.3    Key Customers of the Company
             13.12.4    Key Competitors of the Company
             13.12.5    SWOT Analysis
13.13    TransGen Biotech Co., Ltd.
             13.13.1    Company Overview
             13.13.2    Role of TransGen Biotech Co., Ltd. in the Global Gene Cloning Services Market
             13.13.3    Key Customers of the Company
             13.13.4    Key Competitors of the Company
             13.13.5    SWOT Analysis
13.14    Dobuss (Canvax)
             13.14.1    Company Overview
             13.14.2    Role of Dobuss (Canvax) in the Global Gene Cloning Services Market.
             13.14.3    Key Customers of the Company
             13.14.4    Key Competitors of the Company
             13.14.5    SWOT Analysis
13.15    Azenta US, Inc.
             13.15.1    Company Overview
             13.15.2    Role of Azenta US, Inc. in the Global Gene Cloning Services Market
             13.15.3    Key Customers of the Company
             13.15.4    Key Competitors of the Company
             13.15.5    Financials
             13.15.6    Key Insights about the Financial Health of the Company
             13.15.7    SWOT Analysis
13.16    Macrogen, Inc.
             13.16.1    Company Overview
             13.16.2    Role of Macrogen, Inc. in the Global Gene Cloning Services Market
             13.16.3    Key Customers of the Company
             13.16.4    Key Competitors of the Company
             13.16.5    SWOT Analysis
13.17    Codex DNA, Inc.
             13.17.1    Company Overview
             13.17.2    Role of Codex DNA, Inc. in the Global Gene Cloning Services Market
             13.17.3    Key Customers of the Company
             13.17.4    Key Competitors of the Company
             13.17.5    SWOT Analysis

Table 1:    COVID-19 Impact on Global Gene Cloning Services Market
Table 2:    Products Launched by Various Key Players for Gene Cloning Services Research
Table 3:    Companies/Institute Offering Research Grants
Table 4:    Synergistic Activities Undertaken by Companies in the Global Gene Cloning Services Market
Table 5:    Efficiency Rate in the Global Gene Cloning Services Market
Table 6:    Companies Expanding Business in Global Gene Cloning Services Market
Table 7:    Companies Offering Gene Cloning Services in the Market
Table 8:    List of Companies Providing Gene Synthesis Service
Table 9:    List of Companies Providing Molecular Biology Service
Table 10:    List of Companies Providing Custom Cloning Service
Table 11:    List of Companies Providing Other Service

Figure 1:    Annual NIH Funding in Human Genomics Research, $Billion, FY2013-FY2020
Figure 2:    Global Gene Cloning Services: Market Dynamics
Figure 3:    Share of Key Market Strategies and Developments, January 2018-December 2021
Figure 4:    Global Gene Cloning Services Market Snapshot, $Million, 2020-2031
Figure 5:    Global Gene Cloning Services Market (by Service), $Million, 2020 Vs. 2031
Figure 6:    Global Gene Cloning Services Market (by Gene Type), $Million, 2020 Vs. 2031
Figure 7:    Global Gene Cloning Services Market (by Application), $Million, 2020 Vs. 2031
Figure 8:    Global Gene Cloning Services Market (by End User), $Million, 2020 Vs. 2031
Figure 9:    Global Gene Cloning Services Market (by Region), $Million, 2020 Vs. 2031
Figure 10:    Figure 10: Global Gene Cloning Services Market Segmentation
Figure 11:    Global Gene Cloning Services Market Research Methodology
Figure 12:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 13:    Top-Down Approach (Segment-Wise Analysis)
Figure 14:    Classification of Gene Cloning Service
Figure 15:    Personalized Care for Cancer Patients
Figure 16:    Classification of Gene Cloning Service (by Service)
Figure 17:    Global Gene Cloning Services Market, $Million, 2020-2031
Figure 18:    Pre-COVID-19 and Post-COVID-19 Scenario of Global Gene Cloning Services Market, $Million, 2019-2025
Figure 19:    Impact of COVID-19 on Gene Cloning Services Market
Figure 20:    Share of Key Developments and Strategies, January 2018-January 2022
Figure 21:    Share of Synergistic Activities (by Company), January 2018-January 2022
Figure 22:    Share of Acquisition (by Company), January 2018-January 2022
Figure 23:    Share of Business Expansion Activities (by Company), January 2018-January 2022
Figure 24:    Share of Services Launches (by Company), January 2018-January 2022
Figure 25:    Market Share Analysis for Global Gene Cloning Services Market, $Million, 2019 and 2020
Figure 26:    Growth-Share Analysis of Global Gene Cloning Services Market (by Company), 2019-2020
Figure 27:    Responsibilities of the National Medical Products Administration (NMPA)
Figure 28:    Global Gene Cloning Services Market Dynamics
Figure 29:    Troubleshooting Guide for Cloning
Figure 30:    Global Gene Cloning Services Market (by Service)
Figure 31:    Share of Global Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 32:    Global Gene Cloning Services Market (Gene Synthesis Service), $Million, 2020-2031
Figure 33:    Global Gene Cloning Services Market (Molecular Biology Service), $Million, 2020-2031
Figure 34:    Figure 34: Global Gene Cloning Services Market (PCR Cloning and Sub Cloning Service, by Molecular Biology Service), $Million, 2020-2031
Figure 35:    Global Gene Cloning Services Market (Site-Directed Mutagenesis, by Molecular Biology Service), $Million, 2020-2031
Figure 36:    Global Gene Cloning Services Market (Other Service, by Molecular Biology Service), $Million, 2020-2031
Figure 37:    Global Gene Cloning Services Market (Custom Cloning Service), $Million, 2020-2031
Figure 38:    Figure 38: Global Gene Cloning Services Market (Other Service), $Million, 2020-2031
Figure 39:    Global Gene Cloning Services Market (by Gene Type)
Figure 40:    Share of Global Gene Cloning Services Market (by Gene Type), $Million, 2020 and 2031
Figure 41:    Global Gene Cloning Services Market (Stranded Gene), $Million, 2020-2031
Figure 42:    Global Gene Cloning Services Market (Complex Gene), $Million, 2020-2031
Figure 43:    Global Gene Cloning Services Market (Other Gene Type), $Million, 2020-2031
Figure 44:    Share of Global Gene Cloning Services Market (by Application), $Million, 2020 and 2031
Figure 45:    Global Gene Cloning Services Market (Gene Synthesis), $Million, 2020-2031
Figure 46:    Global Gene Cloning Services Market (Gene Expression), $Million, 2020-2031
Figure 47:    Global Gene Cloning Services Market (Gene Therapy), $Million, 2020-2031
Figure 48:    Global Gene Cloning Services Market (Vaccine Research) $Million, 2021-2031
Figure 49:    Global Gene Cloning Services Market (Other), $Million, 2021-2031
Figure 50:    Share of Global Gene Cloning Services Market (by End User), $Million, 2020 and 2031
Figure 51:    Global Gene Cloning Services Market (Academic and Research Institutions), $Million, 2020-2031
Figure 52:    Global Gene Cloning Services Market (Clinical Laboratories), $Million, 2020-2031
Figure 53:    Global Gene Cloning Services Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031
Figure 54:    Global Gene Coning Services Market (Other End User), $Million, 2020-2031
Figure 55:    Global Gene Cloning Services Market (by Region), $Million, 2020-2031
Figure 56:    Share of North America Gene Cloning Services Market Revenue (by Country), $Million, 2020 and 2031
Figure 57:    North America: Market Dynamics
Figure 58:    Share of North America Gene Cloning Services Market Revenue (by Service), $Million, 2020 and 2031
Figure 59:    North America Gene Synthesis Service Market, $Million, 2020-2031
Figure 60:    North America Molecular Biology Service Market, $Million, 2020-2031
Figure 61:    North America Custom Cloning Service Market, $Million, 2020-2031
Figure 62:    North America Other Service Market, $Million, 2020-2031
Figure 63:    U.S. Gene Cloning Services Market, $Million, 2020-2031
Figure 64:    Canada Gene Cloning Services Market, $Million, 2020-2031
Figure 65:    Europe Gene Cloning Services Market (by Country), $Million, 2020 and 2031
Figure 66:    Europe: Market Dynamics
Figure 67:    Europe Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 68:    Europe Gene Synthesis Service Market, $Million, 2020-2031
Figure 69:    Europe Molecular Biology Service Market, $Million, 2020-2031
Figure 70:    Europe Custom Cloning Service Market, $Million, 2020-2031
Figure 71:    Europe Other Service Market, $Million, 2020-2031
Figure 72:    Germany Gene Cloning Services Market, $Million, 2020-2031
Figure 73:    U.K. Gene Cloning Services Market, Million, 2020-2031
Figure 74:    France Gene Cloning Services Market, $Million, 2020-2031
Figure 75:    Italy Gene Cloning Services Market, $Million, 2020-2031
Figure 76:    Spain Gene Cloning Services Market, $Million, 2020-2031
Figure 77:    Switzerland Gene Cloning Services Market, $Million, 2020-2031
Figure 78:    Rest-of-Europe Gene Cloning Services Market, $Million, 2020-2031
Figure 79:    Asia-Pacific: Market Dynamics
Figure 80:    Asia-Pacific Gene Cloning Services Market (by Country), $Million, 2020 and 2031
Figure 81:    Asia-Pacific Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 82:    Asia-Pacific Gene Synthesis Service Market, $Million, 2020-2031
Figure 83:    Asia-Pacific Molecular Biology Service Market, $Million, 2020-2031
Figure 84:    Asia-Pacific Custom Cloning Service Market, $Million, 2020-2031
Figure 85:    Asia-Pacific Other Service Market, $Million, 2020-2031
Figure 86:    China Gene Cloning Services Market, $Million, 2020-2031
Figure 87:    India Gene Cloning Services Market, $Million, 2020-2031
Figure 88:    Japan Gene Cloning Services Market, $Million, 2020-2031
Figure 89:    Australia Gene Cloning Services Market, $Million, 2020-2031
Figure 90:    South Korea Gene Cloning Services Market, $Million, 2020-2031
Figure 91:    Rest-of-Asia-Pacific Gene Cloning Services Market, $Million, 2020-2031
Figure 92:    Latin America: Market Dynamics
Figure 93:    Latin America Gene Cloning Services Market (by Country), $Million 2020-2031
Figure 94:    Latin America Gene Cloning Services Market (by Service), $Million 2020 and 2031
Figure 95:    Latin America (LATAM) Gene Synthesis Service Market, $Million, 2020-2031
Figure 96:    Latin America (LATAM) Molecular Biology Service Market, $Million, 2020-2031
Figure 97:    Latin America (LATAM) Custom Cloning Service Market, $Million, 2020-2031
Figure 98:    Latin America (LATAM) Other Service Market, $Million, 2020-2031
Figure 99:    Brazil Gene Cloning Services Market, $Million, 2020-2031
Figure 100:    Mexico Gene Cloning Services Market, $Million, 2020-2031
Figure 101:    Rest-of-Latin America Gene Cloning Services Market, $Million, 2020-2031
Figure 102:    Rest-of-the-World Gene Cloning Services Market, $Million, 2020-2031
Figure 103:    Rest-of-the-World Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 104:    Rest-of-the-World (RoW) Gene Synthesis Service Market, $Million, 2020-2031
Figure 105:    Rest-of-the-World (RoW) Molecular Biology Service Market, $Million, 2020-2031
Figure 106:    Rest-of-the-World (RoW) Custom Cloning Service Market, $Million, 2020-2031
Figure 107:    Rest-of-the-World (RoW) Other Service Market, $Million, 2020-2031
Figure 108:    Share of Key Companies Profiled
Figure 109:    Thermo Fisher Scientific, Inc.: Service Portfolio
Figure 110:    Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
Figure 111:    Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 112:    Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018-2020
Figure 113:    Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
Figure 114:    Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 115:    Eurofins Scientific: Service Portfolio
Figure 116:    Eurofins Scientific: Overall Financials, $Million, 2018-2020
Figure 117:    Eurofins Scientific: Revenue (by Region), $Million, 2018-2020
Figure 118:    Eurofins Scientific: SWOT Analysis
Figure 119:    GenScript: Service Portfolio
Figure 120:    GenScript: Overall Financials, $Million, 2018-2020
Figure 121:    GenScript: Revenue (by Business Segment), $Million, 2018-2020
Figure 122:    GenScript: Revenue (by Region), $Million, 2018-2020
Figure 123:    GenScript: R&D Expenditure, $Million, 2018-2020
Figure 124:    GenScript: SWOT Analysis
Figure 125:    Merck KGaA: Service Portfolio
Figure 126:    Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 127:    Merck KGaA: Revenue (by Business Segment), $Million, 2019-2021
Figure 128:    Figure 123 Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 129:    Merck KGaA: R&D Expenditure, $Million, 2019-2021
Figure 130:    Merck KGaA: SWOT Analysis
Figure 131:    Takara Bio Inc.: Service Portfolio
Figure 132:    Takara Bio Inc.: Overall Financials, $Million, 2018-2020
Figure 133:    Takara Bio Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 134:    Takara Bio Inc.: Revenue (by Region), $Million, 2018-2020
Figure 135:    Takara Bio Inc.: R&D Expenditure, $Million, 2018-2021
Figure 136:    Takara Bio Inc.: SWOT Analysis
Figure 137:    Charles River Laboratories Service Portfolio
Figure 138:    Charles River Laboratories: Overall Financials, $Million, 2018-2020
Figure 139:    Charles River Laboratories: Revenue (by Business Segment), $Million, 2018-2020
Figure 140:    Charles River Laboratories.: Revenue (by Region), $Million, 2018-2020
Figure 141:    Charles River Laboratories: SWOT Analysis
Figure 142:    Lonza: Service Portfolio
Figure 143:    Lonza: Overall Financials, $Million, 2019-2021
Figure 144:    Lonza: Revenue (by Business Segment), $Million, 2019-2021
Figure 145:    Lonza: SWOT Analysis
Figure 146:    Sartorius AG: Service Portfolio
Figure 147:    Sartorius AG: Overall Financials, $Million, 2019-2021
Figure 148:    Sartorius AG: Revenue (by Business Segment), 2019-2021
Figure 149:    Sartorius AG: Revenue (by Region), $Million, 2019-2021
Figure 150:    Sartorius AG: SWOT Analysis
Figure 151:    Creative Biogene: Service Portfolio
Figure 152:    Creative Biogene.: SWOT Analysis
Figure 153:    Cellecta, Inc.: Service Portfolio
Figure 154:    Cellecta, Inc.: SWOT Analysis
Figure 155:    Synbio Technologies: Service Portfolio
Figure 156:    Synbio Technologies: SWOT Analysis
Figure 157:    TransGen Biotech Co., Ltd.:  Service Portfolio
Figure 158:    TransGen Biotech Co., Ltd.: SWOT Analysis
Figure 159:    Dobuss (Canvax): Service Portfolio
Figure 160:    Dobuss (Canvax): SWOT Analysis
Figure 161:    Azenta US, Inc.: Service Portfolio
Figure 162:    Azenta US, Inc.: Overall Financials, $Million, 2018-2020
Figure 163:    Azenta US, Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 164:    Azenta US, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 165:    Azenta US, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 166:    Azenta US, Inc.: SWOT Analysis
Figure 167:    Macrogen, Inc.: Service Portfolio
Figure 168:    Macrogen, Inc.: SWOT Analysis
Figure 169:    Codex DNA, Inc.: Service Portfolio
Figure 170:    Codex DNA, Inc.: SWOT Analysis

Market Report Coverage

Gene Cloning Services Market

Base Year

2020

Market Size in 2021

$2,338.6 Million

Forecast Period

2021-2031

Value Projection and Estimation by 2031

$11,524.4 Million

CAGR During Forecast Period

17.29%

Number of Tables

11

Number of Pages

197

Number of Figures

170

Market Segmentation

•    Service (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, and Other Service)

•    Gene Type (Standard Gene, Complex Gene, and Other Gene Type)

•    Application (Gene Synthesis, Gene Expression, Vaccine Research, Gene Therapy, and Other)

•    End User (Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User)

Regional Segmentation

•    North America: U.S. and Canada

•    Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe

•    Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific

•    Latin America: Brazil, Mexico, and Rest-of-Latin America

•    Rest-of-the-World

Market Growth Drivers

•    Favorable Funding Scenario for Gene Synthesis and Cloning Services

•    Technological Advancement in Cloning and Sub Cloning Services

•    Rise in Synergistic Activities in Market

Market Challenges

•    Complications Associated with Large-Scale Production of Cloning Vectors

•    Lower Transfection Efficiency

Market Opportunities

•    Rise in Demand for Gene and Cloning Services

•    Limitation of Vectors or Plasmid

•    Development of New Economical Technologies and Services

Key Companies Profiled

Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Charles River Laboratories, Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc.

Key Questions Answered in this Report:

•       How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
        o    Service (gene synthesis service, molecular biology service, custom cloning service, and other service)
        o    Gene Type (standard gene, complex gene, and other gene type)
        o    Application (gene synthesis, gene expression, vaccine research, gene therapy, and other)
        o    End User (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end user)
        o    Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
•    What are the major market drivers, challenges, and opportunities in the global gene cloning services market?
•    What are the underlying structures resulting in the emerging trends within the global gene cloning services market?
•    How is each segment of the global gene cloning services market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
•    What are the key developmental strategies implemented by the major players to sustain in the competitive market?
•    What are the key regulatory implications in developed and developing regions for the gene cloning services market?
•    Who are the leading players with significant offerings to the global gene cloning services market? What is the current market dominance for each of these leading players?
•    What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which gene cloning service gene type is anticipated to have the most promising growth?
•    What are the key applications in the global gene cloning services market? What are the major segments of these applications? What services are dominating these application segments?
•    What are the major services that are employed in the global gene cloning services market? Which is the dominating service?
•    Who are the primary end users of the global gene cloning services market? Which is the fastest-growing end-user segment in the global gene cloning services market?
•    Who are the key manufacturers in the global gene cloning services market, and what are their contributions? Also, what is the growth potential of each major gene cloning services manufacturer?
•    What is the scope of the global gene cloning services market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which gene cloning service application and end user dominate these regions?
•    What are the emerging trends in the global gene cloning services market? How are these trends revolutionizing the diagnostic procedure?
•    Which companies are anticipated to be highly disruptive in the future and why?
•    What are the regulatory procedures that are required to unify the approval process for emerging gene cloning services? How will these enhance the reimbursement scenario?
•    What are the gaps in regularizing optimum gene cloning services adoption in regular healthcare routines? How can these gaps be tackled?

Report Summary

Market Overview

Gene cloning is an essential part of medical decision-making and aid in acquiring information for a wide range of treatment dissemination, accentuating its criticality in healthcare. Gene cloning has a critical role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics.

The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.

Figure: Global Gene Cloning Services Market Snapshot

Global Gene Cloning Services Market

Source: BIS Research Analysis

Factors fueling the growth of the market include a favorable funding scenario for gene synthesis and cloning services, technological advancement in cloning and subcloning services, and a rise in synergistic activities in the market. Despite rapid advancement in the industry, several key issues need to be addressed to facilitate future growth. Complications associated with large-scale production of cloning vectors and lower transfection efficiency are hampering market growth. Further, some opportunities, such as the rise in demand for gene and cloning services, the limitation of vectors or plasmids, and the development of new economic technologies and services, provide growth to the market.

Within the research report, the market has been segmented on the basis of service, gene type, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the prevalence of infectious diseases and various types of cancer on the regional level has created a buzz among companies to invest in advanced technologies such as gene cloning services.

Based on region, Asia-Pacific holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.

You may also like

Published Year:2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...

Published Year:2018

Global NGS Informatics and Clinical Genomics Market: Focus on Product Types (LIMS, Data Analysis and

As of 2019, the global NGS informatics and clinical genomics market was estimated to be...

Gene Cloning Services Market - A Global and Regional Analysis

Focus on Service, Gene Type, Application, End User, and Region - Analysis and Forecast, 2021-2031